SenesTech Announces Closing of Warrant Exercise for $2.3 Million in Gross Proceeds

PHOENIX, Aug. 23, 2024 /PRNewswire/ — SenesTech, Inc. (NASDAQ: SNES, “SenesTech” or the “Company”), the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of an exercise of certain existing…